Enhanced Neuromelanin Formation and Dopamine Release via Light and Chemical Therapy ID: 2013-007

Technology Overview

This technology introduces a non-invasive approach to stimulate dopamine release and neuromelanin production in the brain using a combination of short-wavelength blue light and flavones. Unlike traditional methods that rely on electrical stimulation, this technique leverages the natural auto-oxidation process of dopamine in the presence of light, flavones, and iron. Initially tested in rodents, it holds promise for treating conditions associated with dopamine deficiency.

Key Advantages

• Non-invasive compared to electrical stimulation methods
• Utilizes natural biochemical processes for neuromelanin and dopamine production
• Offers a novel approach for treating dopamine-related disorders
• Potential for broader application beyond Parkinson's and addiction treatment
• Supported by preliminary research and a provisional patent

Problems Addressed

• Limitations of current dopamine stimulation methods
• Lack of non-invasive treatments for neuromelanin production enhancement
• Challenges in treating dopamine-related conditions like Parkinson's and addiction

Market Applications

• Treatment of Parkinson's disease
• Therapies for addiction and other dopamine deficiency disorders
• Research tools for studying dopamine and neuromelanin dynamics in the brain

Additional Information

Technology ID: 2013-007
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 13 May, 2025